Copyright
©The Author(s) 2020.
World J Stem Cells. Nov 26, 2020; 12(11): 1276-1294
Published online Nov 26, 2020. doi: 10.4252/wjsc.v12.i11.1276
Published online Nov 26, 2020. doi: 10.4252/wjsc.v12.i11.1276
Exosome origin | Disease | MiRNA | Downstream molecular/pathway(s) | Outcome |
BM-MSCs | Osteosarcoma | MiR-208a | Downregulation of PDCD4 and activation of the ERK1/2 pathway | Promoting tumor progression[119] |
BM-MSCs | Multiple myeloma | MiR-146a | The Notch pathway | Promoting tumor progression[121] |
BM-MSCs | Colon cancer | MiR-142-3p | Downregulation of Numb | Promoting tumor progression |
BM-MSCs | Breast cancer | MiR-23b | Decreased MARCKS expression | Inhibiting tumor progression[128] |
MiR-122-transfected AMSCs | HCC | MiR-122 | without research | Inhibiting tumor progression[129] |
BM-MSCs | Prostate cancer | MiR-143 | TFF3 | Inhibiting tumor progression[70] |
MSCs | Breast cancer | MiR-100 | VEGF | Inhibiting tumor progression[166] |
- Citation: Xu HK, Chen LJ, Zhou SN, Li YF, Xiang C. Multifunctional role of microRNAs in mesenchymal stem cell-derived exosomes in treatment of diseases. World J Stem Cells 2020; 12(11): 1276-1294
- URL: https://www.wjgnet.com/1948-0210/full/v12/i11/1276.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v12.i11.1276